Trial Profile
A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Feb 2022
Price :
$35
*
At a glance
- Drugs Mometasone (Primary)
- Indications Perennial allergic rhinitis
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme; Organon; Schering-Plough
- 01 Sep 2008 New trial record.